R1 RCM to restate previously issued financial statements for 2021, 2022 and the first two quarters of 2023 due to errors in accounting for certain acquiree compensation costs.
By Will Feuer R1 RCM, a technology supplier to the healthcare industry, said it will restate its financial statements for 2021, 2022 and the first two.
Operator: Thank you for standing by. My name is Sydney and I will be your conference operator today. At this time, I would like to welcome everyone to the R1 RCM Q3 Earnings Call.
R1 RCM Inc. (NASDAQ:RCM) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Thank you for standing by. My name is Sydney and I will be your conference operator today. At this time, I would like to welcome everyone to the R1 RCM Q3 Earnings Call. [Operator Instructions] Thank you. Evan Smith, you may now […]